B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 720 KRW 1.51%
Market Cap: 481.3B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BioNote Inc
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Other Current Liabilities
â‚©3.9B
CAGR 3-Years
-70%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Other Current Liabilities
â‚©430.7B
CAGR 3-Years
5%
CAGR 5-Years
18%
CAGR 10-Years
18%
SK Bioscience Co Ltd
KRX:302440
Other Current Liabilities
â‚©104.4B
CAGR 3-Years
-9%
CAGR 5-Years
35%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Other Current Liabilities
â‚©42.2B
CAGR 3-Years
16%
CAGR 5-Years
22%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Other Current Liabilities
â‚©40.1B
CAGR 3-Years
41%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Other Current Liabilities
â‚©12.2B
CAGR 3-Years
30%
CAGR 5-Years
40%
CAGR 10-Years
N/A
No Stocks Found

BioNote Inc
Glance View

Market Cap
481.7B KRW
Industry
Biotechnology

BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.

Intrinsic Value
4 394.57 KRW
Overvaluation 7%
Intrinsic Value
Price
B

See Also

What is BioNote Inc's Other Current Liabilities?
Other Current Liabilities
3.9B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Other Current Liabilities amounts to 3.9B KRW.

What is BioNote Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 3Y
-70%

Over the last year, the Other Current Liabilities growth was -90%. The average annual Other Current Liabilities growth rates for BioNote Inc have been -70% over the past three years .

Back to Top